Johnson & Johnson Sues Barr Laboraties Over Contraceptive

Law360, New York (October 12, 2003, 12:00 AM EDT) -- Healthcare company Johnson & Johnson has filed a lawsuit to block Barr Laboratories from selling a generic form of its Ortho Tri-Cyclen Lo oral contraceptive, Bloomberg News reported. Johnson & Johnson's Ortho-McNeil Pharmaceutical unit claims the generic version would infringe its patented technology.

Barr applied to the Food and Drug Administration in June to sell a generic version of the contraceptive. The pill, with $110 million in sales per year, was introduced in September 2002.

The suit automatically blocks the F.D.A. from granting final approval for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.